Recombinant Human IL-11

Home/Recombinant Proteins/Recombinant Human IL-11

Pricing & Details

Product. No.I-194
Alternate Names
Interleukin-11, AGIF(Adipogenesis Inhibitory Factor)
Expression Host
Sf 21 Insect Cells
Species
Human
Prod No.
Size
Price
Avail.
Qty
Add to cart
I-194-5 µg
5 µg
$259.00
In stock
Max:
Min: 1
Step: 1
I-194-25 µg
25 µg
$849.00
In stock
Max:
Min: 1
Step: 1

Data

Background

Interleukin 11 (IL-11), also known as AGIF, is a member of the IL-6-type cytokine family and key regulator of multiple events in hemtaopoiesis. It stimulates growth of myeloid, erythroid and megakaryocyte progenitor cells.1 IL-11 also regulates bone metabolism, inhibits production of proinflammatory cytokines and protects against gastromucosal injury.2 Compared to other interleukins, IL-11 is relatively under-characterized. It is secreted by bone marrow stromal cells (fibroblasts) and is produced also by a number of mesenchymal cells. IL-11 is expressed in a wide variety of tissues including thymus, lung, bone, connective tissue and central nervous system. Signal transduction is initiated upon binding of IL-11 to IL-11Rα and gp130, facilitating the homodimerization of gp130 molecules.2 This permits gp130-associated JAK kinases to become activated and phosphorylate intracellular tyrosine residues on gp130. IL-11 shares many functions of IL-6 and LIF, including potentiation of megakaryocyte activity, enhancement of human myeloma cell proliferation and enhancement of hepatic acute phase protein production.3 It has been found to stimulate the T cell dependent development of specific immunoglobulin-secreting B cells.4 Clinically, IL-11 is used to prevent severe thrombocytopenia and the reduction of the need for platelet transfusion following myelosuppressive chemotherapy. Another possible application may be as a therapeutic for osteoporosis.

Protein Details

Purity
>97% by SDS-PAGE and analyzed by silver stain.
Endotoxin Level
<0.1 EU/µg as determined by the LAL method
Biological Activity
The biological activity of Human IL-11 was determined by a cell proliferation assay using T11, a subline of the IL-6-dependent murine plasmacytoma cell line T1165.85.2.1 that has been adapted to grow in IL-11. (Nordan, R.P., Pumphrey, J.G., and B. Rudikoff, 1987, J. Immunol. 139:813). The expected ED50 for this effect is typically 0.06 - 0.24 ng/ml.
Expression Host
Sf 21 Insect Cells
Protein Accession No.
Amino Acid Sequence
pgpppgppr vspdpraeld stvlltrsll adtrqlaaql rdkfpadgdh nldslptlam sagalgalql pgvltrlrad llsylrhvqw lrraggsslk tlepelgtlq arldrllrrl qllmsrlalp qpppdppapp lappssawgg iraahailgg lhltldwavr gllllktrl
N-terminal Sequence Analysis
Pro22
State of Matter
Solution
Predicted Molecular Mass
The predicted molecular weight of Recombinant Human IL-11 is Mr 19 kDa. However, the actual molecular weight as observed by migration on SDS-PAGE is Mr 23 kDa.
Formulation
This recombinant protein solution was 0.2 µm filtered and formulated in modified Dulbecco’s phosphate buffered saline (1X PBS) pH 7.2 – 7.3 with no calcium, magnesium, or preservatives present. The final protein concentration is 0.25 mg/ml.
Storage and Stability
Working aliquots of this recombinant protein solution are stable for up to six months at -20°C to -70°C in a manual defrost freezer. Upon thawing, in the presence of a carrier protein, this recombinant protein can be stored at 2° - 8°C for one month without detectable loss of activity. Product shows no detectable loss in activity after 3 months when aliquoted and stored at -20°C to -70°C in a manual defrost freezer. Avoid repeated freeze thaw cycles.
Country of Origin
USA
Shipping
Next Day 2-8°C
PubMed
NCBI Gene Bank

References & Citations

1. Williams, DA. et al. (1990) Proc. Natl. Acad. Sci. (USA) 87:7512
2. Heinrich, PC. et al. (2003) Biochem. J. 374:1
3. Bauman, H. et al. (1991) J. Biol. Chem. 266:20424
4. Curti, A. et al. (2002) Haematologica 87:373
IMPORTANT Use lot specific datasheet for all technical information pertaining to this recombinant protein.
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Leinco Technologies uses cookies to improve your experience and our website service. By continuing to browse our website, you accept our